Trump tariffs and changes at the FDA with David Lennarz

Key takeaways

The uncertainty surrounding tariffs under the Trump administration is causing significant concern among manufacturers reliant on imports.
U.S. companies are advised to proactively seek alternative suppliers and reignite past supplier relationships to prepare for potential disruptions in their supply chains.
While larger manufacturers may relocate production to the U.S., the process is complex and requires time and capital, impacting smaller businesses more severely.
Retaliatory tariffs imposed by other countries have yet to significantly affect U.S. exporters, who may explore alternative markets in response.
Changes at the FDA may result in streamlined processes and better product safety oversight, benefiting consumers in the long run.

Summary

Impact of Tariffs on U.S. Manufacturers

David Lanars discusses the uncertainty regarding tariffs implemented by the Trump administration, particularly focusing on tariffs affecting imports from Mexico and Canada, the U.S.'s largest trading partners. He highlights how U.S. manufacturers are responding to these changes by considering alternative sourcing options, particularly as some countries like Vietnam reduce tariffs on U.S. products. The potential for increased consumer prices in the retail sector due to these tariffs is a major concern, as costs are often passed along the supply chain.

Preparing for Supply Chain Disruptions

Lanars emphasizes the need for U.S. companies to consult their ’COVID playbook’ to mitigate supply chain disruptions caused by these tariffs. Companies should actively research alternative suppliers and rekindle relationships to ensure they can pivot if necessary. This preparation is crucial for maintaining competitiveness in the global market.

Effects of Tariffs on U.S. Exports and Production

The discussion extends to whether the tariffs will lead to increased manufacturing in the U.S. Lanars points out that while some larger companies may relocate production closer to U.S. consumers, this process takes significant time and capital investment. Many smaller companies may not have the resources to make such a shift and could instead look to expand into growing markets in Asia.

Retaliatory Tariffs and Their Consequences

Lanars notes that retaliatory tariffs imposed by countries like China, Canada, and the EU have not influenced U.S. exporters significantly at this point. However, he expects U.S. exporters to adapt by exploring markets where they can remain competitive without facing high tariffs.

Changes at the FDA Under the Trump Administration

The conversation touches on anticipated policy changes at the FDA under new leadership, with a focus on potential job cuts. Lanars believes these changes could impact product reviews and approvals, but also presents an opportunity for simplification in labeling and regulations to benefit consumers. He notes the ongoing importance of the FDA’s role in ensuring the safety of food, drugs, and other consumer products.

Show notes

The president of Registrar Corp. discusses what Trump's tariffs might mean for US and international manufacturers and potential changes at the FDA under HHS Secretary Robert F. Kennedy Jr.